Ömrüm Uzun - Concepedia

Author

Ömrüm Uzun

Hacettepe University ORCID

Also Known As

Holmes, D., Nurgul Ceran, Nurgül Ceran, O UZUN, O Uzun, O. UZUN, O. Uzun, Omrum UZUN, Omrum Uzun, Omrüm Uzun

137

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

Hacettepe University The University of Texas MD Anderson Cancer Center Statens Serum Institut Canisius-Wilhelmina Ziekenhuis Hippocration General Hospital

ÖU

About

Ömrüm Uzun is an author at Hacettepe University specializing in medicine, infection control, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	25	2.1K
2	Health Sciences	11	11	1.5K
3	Epidemiology	6	6	990
4	Public Health	3	3	233
5	Gastroenterology	2	2	86

Ömrüm Uzun

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
The Epidemiology of Hematogenous Candidiasis Caused by Different Candida Species Dima Abi‐Said, Elias Anaissie, Ömrüm Uzun, Clinical Infectious Diseases Fluconazole ProphylaxisAntifungal AgentMedical RecordsIntensive Care UnitHealth Sciences	1997	761
The effects of blood group types on the risk of COVID-19 infection and its clinical outcome Hakan Göker, Elifcan Aladağ, Halûk Demiroğlu, TURKISH JOURNAL OF MEDICAL SCIENCES	2020	206
Fluconazole versus Amphotericin B in the treatment of Hematogenous Candidiasis: A matched cohort study Elias Anaissie, S. E. Vartivarian, Dima Abi-Said, The American Journal of Medicine Antifungal AgentHealth SciencesAntifungal AgentsHematogenous CandidiasisHematology	1996	187
Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss Dolunay Gülmez, Neil Woodford, Marie-France I. Palepou, International Journal of Antimicrobial Agents Medical MicrobiologyAntimicrobial Resistance GeneAntimicrobial SusceptibilityHealth SciencesKlebsiella Pneumoniae	2008	162
Risk Factors and Predictors of Outcome in Patients with Cancer and Breakthrough Candidemia Ömrüm Uzun, Sibel Aşçıoğlu, Elias Anaissie, Clinical Infectious Diseases Cancer ManagementPrognosisPathologyClinical MycologyBt Candidemia	2001	135
Quinolones in treatment of human brucellosis: comparative trial of ofloxacin-rifampin versus doxycycline-rifampin Murat Akova, Ömrüm Uzun, Mutlu Hayran, Antimicrobial Agents and Chemotherapy Gastric DiscomfortBrucella SpeciesAntimicrobial SusceptibilityHealth SciencesAntimicrobial Stewardship	1993	127
Antifungal prophylaxis in patients with hematologic malignancies: a reappraisal [see comments] Ömrüm Uzun, EJ Anaissie Blood Antifungal AgentOncologyAntibioticsAntifungal AgentsHematology	1995	107
Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon? Tamara Zoran, Bettina Sartori, Laura Sappl, Frontiers in Microbiology	2018	86
Diarrhea in neutropenic patients: a prospective cohort study with emphasis on neutropenic enterocolitis Dürdane Aksoy, Ömrüm Uzun, Pınar Zarakolu, Annals of Oncology Neutropenic PatientsClinical EpidemiologyGastroenterologyClinical GastroenterologyNeutropenic Enterocolitis	2006	73
In vitro activity of a new echinocandin, LY303366, compared with those of amphotericin B and fluconazole against clinical yeast isolates Ömrüm Uzun, Sesın Kocagöz, Yeşim Çetinkaya, Antimicrobial Agents and Chemotherapy Yeast IsolatesClinical MycologyAntimicrobial ChemotherapyDrug ResistanceAmphotericin B	1997	72

Page 1